Jeil wins lawsuit over patent troll

Published: 2013-05-08 07:00:00
Updated: 2013-05-08 07:00:00
Jeil Pharmaceutical scored a victory in a patent dispute of Baraclude (entecavir) against BMS Korea.

The Korean company said Monday that the Korean Intellectual Property Tribunal had ruled in favor of Jeil last week, which it expects will boost its entecavir business in the domestic market, wh...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.